When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FOLD - Amicus Should Be On Your Radar As It Makes Progress On Multiple Fronts Using Gene Therapy
Amicus Therapeutics Inc.
Amicus Therapeutics (FOLD) had achieved positive Interim results using its gene therapy to treat patients with Batten disease. This proves that the biotech's gene therapy was able to halt the progression of the disease and offer the ability to improve motor and language functions in patients with this disease. This preliminary data bodes well to advance the gene therapy for the other types of Batten disease being targeted in the pipeline. Best of all is that the company intends to release additional data from this phase 1/2 study throughout the rest of this